Table 2. In vivo LV hemodynamic measures on mice at baseline.
NTG | cTnIS200D | cTnIS200A | |
---|---|---|---|
Measures | |||
Heart Rate (beat/min) | 580 ± 12 | 554 ± 14 | 578 ± 16 |
Main Arterial Pressure (mmHg) | 76.64 ± 4.46 | 67.53 ± 2.75 | 71.54 ± 1.82 |
End-systolic Pressure (mmHg) | 94.16 ± 5.15 | 82.25 ± 3.54 | 87.40 ± 2.66 |
End-diastolic Pressure (mmHg) | 4.71 ± 0.39 | 7.34 ± 0.76 * | 4.89 ± 0.51 |
End-systolic Volume (μl) | 14.69 ± 0.38 | 14.98 ± 0.36 | 14.37 ± 1.18 |
End-diastolic Volume (μl) | 39.57 ± 0.97 | 40.19 ± 0.54 | 39.38 ± 1.48 |
Stroke Volume (μl) | 24.88 ± 1.08 | 25.21 ± 0.68 | 25.01 ± 0.61 |
Cardiac Output (ml/min) | 14.44 ± 0.76 | 13.95 ± 0.43 | 14.44 ± 0.50 |
Arterial Elastance | 3.82 ± 0.22 | 3.29 ± 0.19 | 3.50 ± 0.10 |
Systolic Indices | |||
Ejection Fraction (%) | 62.67 ± 1.34 | 62.66 ± 1.04 | 63.97 ± 1.99 |
dP/dtmax (mmHg/s) | 11096 ± 1015 | 11628 ± 760 | 10324 ± 374 |
dP/dtmax/iP (s-1) | 188.61 ± 9.41 | 226.02 ± 7.89 * | 189.57 ± 4.34 |
Powermax/EDV | 38.27 ± 3.18 | 27.97 ± 2.05 * | 36.38 ± 1.97 |
SW | 2402 ± 200 | 2114 ± 76 | 2253 ± 99 |
PRSW | 87.17 ± 6.82 | 93.06 ± 8.36 | 91.79 ± 4.81 |
Diastolic Indices | |||
dP/dtmin | 9130 ± 901 | 6255 ± 483 * | 8412 ± 498 |
Tau (ms) | 5.27 ± 0.36 | 6.90 ± 0.38 * | 5.25 ± 0.21 |
Peak Filling Rate-EDV | 36.93 ± 2.61 | 28.51 ± 1.79 † | 31.01 ± 1.95 |
P<0.05 compared to NTG and cTnIS200A.
P<0.05 compared to NTG. n=5. End-diastolic volume presents preload. Arterial elastance is a measure of afterload. Abbreviations: EF, ejection fraction; dP/dtmax, peak rate of pressure rise; dP/dtmax/iP, peak rate of pressure normalized to instantaneous pressure, a preload-independent index of contractility during isovolumic contraction; Powermax/EDV, maximal power normalized to EDV reflecting contractility during LV ejection of blood; −dP/dtmin, peak rate of pressure decay during isovolumic relaxation, which is preload dependent; Tau, isovolumic relaxation time constant, a preload-independent index; PFR/EDV, peak ventricular filling rate normalized to EDV.